BLOG

Monday, October 1, 2018

Pfizer replaces long-time CEO Ian Read with veteran Albert Bourla

Pfizer is contending with the expiry of patents on some of its blockbuster drugs

from Companies https://ift.tt/2xPtM27
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...